Over 500 papers were produced by GA²LEN members. Amongst them, approximately 80 papers were published as GA²LEN position papers, practical guides, or “GA²LEN task force papers” with GA²LEN in the title. This impressive number is an indicator of how well the EU’s investment was rewarded: more than one paper per €70.000 is absolutely exceptional among EU projects.
Publications in 2009
- Position paper : EAACI/GA²LEN/EDF/WAO guideline: management of urticaria . T. Zuberbier, R. Asero, C. Bindslev-Jensen, G. Walter Canonica,M. K. Church, A. M. Giménez-Arnau, C. E. H. Grattan, A. Kapp,M. Maurer, H. F. Merk, B. Rogala,S. Saini, M. Sánchez-Borges, P. Schmid-Grendelmeier,H. Schϋnemann, P. Staubach,G. A. Vena, B. Wedi.
- [GA2LEN (Global Allergy and Asthma European Network), the perspective of the German speaking centers]. Wöhrl S, Radon K, Ring J, Moritz K, Akdis C, Burney P, Van Cauwenberge P, Bousquet J, Zuberbier T. Wien Klin Wochenschr. 2009;121(17-18):589-97. German.
- Pharmacovigilance of drug allergy and hypersensitivity using the ENDA–DAHD database and the GA2LEN platform. The Galenda project P.-J. Bousquet, P. Demoly,A. Romano, W. Aberer,A. Bircher, M. Blanca, K. Brockow,W. Pichler, M. J. Torres, I. Terreehorst, B. Arnoux, M. Atanaskovic-Markovic, A. Barbaud, A. Bijl, P. Bonadonna, P. G. Burney, S. Caimmi, G. W. Canonica, J. Cernadas, B. Dahlen, J.-P. Daures, J. Fernandez, E. Gomes, J.-L. Gueant, M. L. Kowalski, V. Kvedariene, P.-M. Mertes, P. Martins, E. Nizankowska-Mogilnicka, N. Papadopoulos, C. Ponvert, M. Pirmohamed, J. Ring, M. Salapatas, M. L. Sanz, A. Szczeklik, E. Van Ganse, A. L. De Weck, T. Zuberbier, H. F. Merk, B. Sachs, A. Sidoroff, Global Allergy, Asthma European Network (GA2LEN) and Drug Allergy and Hypersensitivity Database (DAHD) and the European Network for Drug Allergy (ENDA). Allergy (2009), 64:2, doi: 10.1111/j.1398-9995.2008.01944.x
- Establishing a standardized quality management system for the European Health Network GA2LEN. Heinzerling L, Burbach G, van Cauwenberge P, Papageorgiou P, Carlsen KH, Lødrup Carlsen KC, Zuberbier T.Allergy. 2010 Jun 1;65(6):743-52. Epub 2009 Nov 3.
- The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paper. Bousquet PJ, Brozek J, Bachert C, Bieber T, Bonini S, Burney P, Calderon M, Canonica GW, Compalati E, Daures JP, Delgado L, Demoly P, Dahl R, Durham SR, Kowalski ML, Malling HJ, Merk H, Papadopoulos N, Passalacqua G, Simon HU, Worms M, Wahn U, Zuberbier T, Schünemann HJ, Bousquet J. Allergy. 2009 Dec;64(12):1737-45. Epub 2009 Oct 26.
- GA2LEN skin test study III: minimum battery of test inhalent allergens needed in epidemiological studies in patients. Bousquet PJ, Burbach G, Heinzerling LM, Edenharter G, Bachert C, Bindslev-Jensen C, Bonini S, Bousquet-Rouanet L, Demoly P, Bresciani M, Bruno A, Gjomarkaj M, Canonica GW, Darsow U, Durham S, Fokkens WJ, Giavi S, Gramiccioni C, Papadopoulos NG, Haahtela T, Kowalski ML,Magyar P, Muraközi G, Orosz M, Röhnelt C, Stingl G, Todo-Bom A, von Mutius E, Wiesner A, Wöhrl S, Bousquet J, Zuberbier T.Allergy. 2009 Nov;64(11):1656-62.
- The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis. Compalati E, Passalacqua G, Bonini M, Canonica GW. Allergy. 2009 Nov;64(11):1570-9. Epub 2009 Sep 30. Review.
- The definition and diagnostic testing of physical and cholinergic urticarias--EAACI/GA2LEN/EDF/UNEV consensus panel recommendations. Magerl M, Borzova E, Giménez-Arnau A, Grattan CE, Lawlor F, Mathelier-Fusade P, Metz M, Młynek A, Maurer M; EAACI/GA2LEN/EDF/UNEV. Allergy. 2009 Dec;64(12):1715-21. Epub 2009 Sep 30.
- [GA2LEN (Global Allergy and Asthma European Network)]. Bousquet J, Kauffmann F, Demoly P, Leynaert B, Bousquet PJ, Demenais F, Lenzen G, Burney PG, Zuberbier T, Van Cauwenberge P. Rev Mal Respir. 2009 Jun;26(6):577-86. French.
